Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology
New library preparation solution for targeted next-generation sequencing combines gene panel design customization with ultra-high sensitivity
20 Jun 2018
Thermo Fisher Scientific has announced the launch of its Ion AmpliSeq HD technology, the latest next-generation library preparation innovation that provides clinical researchers with the flexibility to custom design gene panels, without sacrificing the ultra-high sensitivity required to find low-frequency variants in cell-free DNA (cfDNA) and highly heterogeneous solid tumor samples. The new product for targeted next-generation sequencing (NGS) oncology and genetic research applications is being featured at the 2018 European Society of Human Genetics (ESHG) conference (booth #350) in Milan, Italy, and later this month at the 2018 European Association for Cancer Research (EACR) conference (booth #53-54) in Amsterdam, Netherlands.
Until now, clinical researchers have relied on fixed NGS gene panels to carry out applications that require ultra-high sensitivity capability, but the ability to combine panel customization with exceptional sensitivity has long been sought after by customers, particularly for liquid biopsy applications. This has led Thermo Fisher to develop Ion AmpliSeq HD, a new library prep technology that enables custom design flexibility for single nucleotide variations (SNVs), small insertions/deletions (indels), fusions and copy number variation (CNV) detection with a limit of detection (LOD) as low as ≤0.1 percent in blood samples.
"Ion AmpliSeq HD panels allow me to interrogate highly heterogeneous tumor samples for my targets of interest," said John Thompson, Ph.D., IVD Development Leader, Personal Genome Diagnostics (PGDx). "We are able to detect specific variants as low as 0.1 percent, and the workflow allows me flexibility based on my needs."
The heightened sensitivity achieved with Ion AmpliSeq HD is enabled with proprietary molecular tags, while dual barcoding of the fragments of interest helps enhance accuracy in fragment identification and sequencing using the Ion GeneStudio S5 Series instruments. The technology also provides workflow improvements that reduce library preparation time to less than three hours.
Similar to the original Ion AmpliSeq technology, Ion AmpliSeq HD leverages the same two-day, sample-to-answer workflow that's easy to implement in any NGS laboratory. In addition to its successful application in oncology research, Ion AmpliSeq HD has also demonstrated application in inherited disease research, as presented during Thermo Fisher'scustomer talks at ESHG, with potential use in infectious disease research, microbial studies, and gene expression analysis.
"For studying mosaicism in rare genetic diseases, we needed a genetic analysis technology that is highly sensitive and capable of discovering novel variants," said Line H. G. Larsen, head of laboratory, Amplexa Genetics. "Ion AmpliSeq HD solution enables me to detect transmission of pathogenic variants from mosaic parents. With this technology, we look forward to finding new insights about the causes of these types of genetic diseases."
"As oncology research continues to evolve at a rapid pace, so has demand for advanced tools that can keep pace with the needs of our customers," said Andy Felton, vice president, product management for clinical sequencing at Thermo Fisher Scientific. "We have built upon the knowledgebase from our market-leading AmpliSeq technology to now provide a solution that raises the bar for library prep by combining flexibility with ultra-high sensitivity."
Do you use any Thermo Fisher Scientifc products in your lab? Write a review today for you chance to win a $400 Amazon voucher!
Related Products
Request Quote for All Products
Ion AmpliSeq HD Panels for Targeted Next-Generation Sequencing
Thermo Fisher ScientificIon AmpliSeq HD technology is a new amplicon-based library preparation technology for Ion Torrent next-generation sequencing (NGS) that gives you the power to design your own panels and find variants with a low limit of detection—down to 0.1% for cell-free DNA samples. This revolutionary technology enables researchers to routinely get answers when ultrahigh sensitivity is required, such as when detecting low-frequency alleles in circulating tumor DNA or trace pathogenic microbial species in blood. Combined with the Ion GeneStudio S5 sequencers, Ion AmpliSeq HD panels offer a flexible targeted-NGS solution for: Cancer research Infectious disease research Microbial studies Gene expression studies How does Ion AmpliSeq HD technology work? Ion AmpliSeq HD technology leverages unique molecular tags, or UMTs, and the made-to-order design pipeline in Ion AmpliSeq Designer to help deliver results with ultrahigh sensitivity. Unmatched sensitivity for your research As genetic research rapidly evolves, the ability to confidently detect low-frequency variants or quantitate transcript-level expression is becoming more critical to the development of NGS assays with ultrahigh sensitivity. Ion AmpliSeq HD panels have been shown to achieve a 0.1% limit of detection for cell-free DNA samples, with >99% specificity for SNVs, hotspots, indels, CNVs, and fusions. Ion AmpliSeq HD panels support both DNA and RNA samples and require as little as 1 ng nucleic acids input from FFPE samples.
Ion GeneStudio S5 Series
Thermo Fisher ScientificAchieve speed and throughput flexibility across a broad range of next-generation sequencing (NGS) applications with the Ion GeneStudio™ S5 series of benchtop NGS systems from Thermo Fisher Scientific.